Our investments in a new Leeds clinical research unit (CRU) combines our existing breadth of medical resources with new opportunities to grow and drive innovation forward. From increased cGMP pharmacy space to a larger clinic bed capacity, we are expanding our capabilities to optimize Phase I studies for clinicians and volunteers alike.
Driving Precision and Engagement for Phase I Studies
Welcome to the New Leeds Clinic
When it comes to successful Phase I studies, we understand the need to combine state-of-the-art technology with a positive volunteer experience that builds trust and engagement.
We’re driving innovation in clinical trials with increased square footage for beds, cGMP pharmacy, future growth and more.
5 Things to Know About Our New Clinical Research Unit
How will the new CRU promote volunteer recruitment and enhance engagement?
Our proximity to public transportation and parking for cyclists minimizes travel burden to volunteers. Additionally, our dedicated visitor suite is designed to facilitate rapid screening, increasing efficiency and convenience.
When will this CRU be ready to accept new clinical trials?
How many total beds are available for Phase I studies?
We have 100 dedicated beds—including 32 high-visibility beds—with room to grow.
How many pharmacy prep laboratories are available?
The new clinic offers four preparation laboratories—two sterile and two nonsterile to support cGMP pharmacy.
How is the CRU practicing sustainability?
Our BREEAM certification means we have assessed and pursued holistic environmental opportunities to reduce carbon emissions, preserve energy and manage waste responsibly.